Trastuzumab beyond progression in HER2-positive metastatic breast cancer

被引：1
|
作者：
Al-Naqqash, Manwar [1 ,2 ]
Jasim Al-Serarati, Waleed [3 ]
Farooq Kareem, Tara [4 ]
机构：
[1] Univ Baghdad, Dept Surg, Coll Med, Baghdad 10001, Iraq
[2] Minist Hlth Environm, Dept Radiat Oncol, Oncol Teaching Hosp, Baghdad Med City Complex, Baghdad, Iraq
[3] Minist Hlth & Environm, Dept Oncol, Baghdad Med City Complex, Baghdad, Iraq
[4] Minist Hlth & Environm, Oncol Teaching Hosp, Dept Diagnost Radiol, Baghdad Med City Complex, Baghdad, Iraq
来源：
BREAST JOURNAL | 2021年 / 27卷 / 03期
关键词：
breast cancer; HER2; neu; time to progression; trastuzumab;
D O I：
10.1111/tbj.14157
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：297 / 299
页数：3
相关论文
共 50 条
  • [1] Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer
    Park, I. H.
    Ro, J.
    Lee, K. S.
    Nam, B. H.
    Kwon, Y.
    Shin, K. H.
    ANNALS OF ONCOLOGY, 2009, 20 (01) : 56 - 62
  • [2] Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond
    Perez, Jose
    Garrigos, Laia
    Gion, Maria
    Janne, Pasi A.
    Shitara, Kohei
    Siena, Salvatore
    Cortes, Javier
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 811 - 824
  • [3] Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression
    Izzet Dogan
    Esra Aydin
    Nijat Khanmammadov
    Nail Paksoy
    Pinar Saip
    Adnan Aydiner
    Scientific Reports, 13
  • [4] Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression
    Dogan, Izzet
    Aydin, Esra
    Khanmammadov, Nijat
    Paksoy, Nail
    Saip, Pinar
    Aydiner, Adnan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond
    Zardavas, Dimitrios
    Pugliano, Lina
    Ades, Felipe
    Bozovic-Spasojevic, Ivana
    Capelan, Marta
    de Azambuja, Evandro
    BREAST CANCER MANAGEMENT, 2012, 1 (03) : 217 - 233
  • [6] HER2-Positive Breast Cancer: Beyond Trastuzumab
    Murphy, Conleth G.
    Fornier, Monica
    ONCOLOGY-NEW YORK, 2010, 24 (05): : 410 - 415
  • [7] Emerging approaches for treating HER2-positive metastatic breast cancer beyond trastuzumab
    Gradishar, W. J.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2492 - 2500
  • [8] Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer
    Tsang, R. Y.
    Finn, R. S.
    BRITISH JOURNAL OF CANCER, 2012, 106 (01) : 6 - 13
  • [9] Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer
    R Y Tsang
    R S Finn
    British Journal of Cancer, 2012, 106 : 6 - 13
  • [10] Trastuzumab emtansine in HER2-positive metastatic breast cancer
    Montemurro, Filippo
    LANCET ONCOLOGY, 2017, 18 (06): : 696 - 697
12345